- NewLink Genetics Presents Updated NLG802 Results at the Immuno-Oncology 2019 World Congress
- RedHill Biopharma to Present at 2019 BIO International Convention
- BioSig Allowed First Key US Patent Claims for its PURE EP™ System
- Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results
- Incysus Therapeutics to Present at Jefferies 2019 Global Healthcare Conference
- Synthetic Paper Market To Reach USD 973.0 Million by 2026 | Reports And Data
- Sentia Medical Sciences Inc. Awarded Approximately $1.8 million Phase II Small Business Innovation Research (SBIR) Grant to Develop Astressins for the Treatment of Irritable Bowel Syndrome (IBS)
- HIV Cure Program Patent Granted To American Gene Technologies
- Seelos Therapeutics Reports Q1 2019 Pipeline Update
- Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version
